List of Verix CDP Customers
San Jose, CA, 95129-1122,
United States
Since 2010, our global team of researchers has been studying Verix CDP customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Verix CDP for Customer Data Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Verix CDP for Customer Data Platform include: Bayer, a Germany based Life Sciences organisation with 92815 employees and revenues of $55.47 billion, Novartis, a Switzerland based Life Sciences organisation with 75883 employees and revenues of $51.72 billion, Citius Oncology, a United States based Life Sciences organisation with 20 employees and revenues of $4.0 million and many others.
Contact us if you need a completed and verified list of companies using Verix CDP, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Verix CDP customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bayer | Life Sciences | 92815 | $55.5B | Germany | Verix | Verix CDP | Customer Data Platform | 2023 | n/a |
In 2023, Bayer implemented Verix CDP as a Customer Data Platform to support pharma commercial operations across European and global markets. Verix lists Bayer as a customer using the Tovana platform to enable HCP targeting and commercial analytics, reflecting a deployment oriented toward improving commercial execution and uptake.
The Verix CDP implementation consolidated unified HCP and patient data into single profiles, applying AI-driven targeting and patient-finder capabilities alongside segmentation and commercial analytics modules to inform HCP targeting and campaign audience selection. Operational coverage is centered on commercial functions within pharma commercial operations, with vendor descriptions of Tovana indicating the use of unified identity resolution, audience activation and analytics workflows to support targeting and commercial planning.
|
|
|
Citius Oncology | Life Sciences | 20 | $4M | United States | Verix | Verix CDP | Customer Data Platform | 2025 | n/a |
In 2025, Citius Oncology engaged Verix to deploy Verix CDP to support the U.S. commercial launch of LYMPHIR. Verix CDP is being deployed as a Customer Data Platform to improve HCP targeting, field execution, and patient identification for oncology commercialization in the United States.
Deployment centers on Customer Data Platform capabilities including unified identity resolution, persistent HCP and patient profile stitching, rule based segmentation, and real time orchestration to support field workflows and targeting. Verix CDP functionality also includes analytics and activation layers to translate unified profiles into targeted outreach and field execution plans.
The engagement includes integration with Verix AI as announced, with configurations aimed at operationalizing provider engagement signals and patient match criteria for the commercial launch. Operational scope explicitly covers U.S. commercial teams responsible for HCP engagement, field execution, and patient identification workflows during the LYMPHIR launch.
The collaboration was announced November 21, 2025 and is intended to accelerate launch adoption and provider engagement through centralized profile management and activation. Governance and rollout emphasis aligns CDP driven segmentation with commercial campaign workflows and field feedback loops to iteratively refine targeting during the launch period.
|
|
|
Novartis | Life Sciences | 75883 | $51.7B | Switzerland | Verix | Verix CDP | Customer Data Platform | 2023 | n/a |
In 2023 Novartis deployed Verix CDP as a Customer Data Platform to support commercial optimization activities for oncology and specialty brands. The deployment surfaced Verix CDP functionality described by the vendor as enabling dynamic targeting, next-best-action guidance, and patient discovery to inform field and marketing execution.
The implementation consolidated unified HCP and patient data into a single identity layer, enabling audience segmentation and omnichannel orchestration consistent with Customer Data Platform capabilities. Verix CDP was configured to support real-time audience activation and next-best-action workflows, with inferred CDP-aligned features such as identity resolution, segmentation, and orchestration engines used to route guidance to commercial users.
Operational coverage focused on commercial operations, field teams, and marketing organizations supporting oncology and specialty brands, where orchestration fed tailored targeting and patient discovery workflows. The platform was used to drive improved field and marketing outcomes through coordinated omnichannel engagement and prescriptive next-best-action guidance embedded in commercial processes.
Governance centered on centralized customer and patient identity management and campaign orchestration rules to standardize targeting and guidance across teams. The Novartis implementation of Verix CDP emphasized operationalizing data-driven commercial decisioning within existing field and marketing workflows, aligning CDP data models with commercial governance for consistent execution.
|
Buyer Intent: Companies Evaluating Verix CDP
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||